Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 15;171(8):596-598.
doi: 10.7326/M19-0953. Epub 2019 Jul 23.

Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey

Colin W O'Brien  1 , Stephen P Juraschek  2 , Christina C Wee  2
Affiliations

Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey

Colin W O'Brien et al. Ann Intern Med. .
No abstract available

PubMed Disclaimer

References

    1. Capodanno D, Angiolillo DJ. Aspirin for primary cardiovascular risk prevention and beyond in diabetes mellitus. Circulation. 2016;134:1579–94. - PubMed
    1. Bowman L, Mafham M, Wallendszus K, et al.; ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med. 2018;379:1529–39. doi:10.1056/NEJMoa1804988 - DOI - PubMed
    1. Gaziano JM, Brotons C, Coppolecchia R, et al.; ARRIVE Executive Committee. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018;392:1036–46. doi:10.1016/S0140-6736(18)31924-X - DOI - PMC - PubMed
    1. McNeil JJ, Woods RL, Nelson MR, et al.; ASPREE Investigator Group. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018; 379:1499–508. doi:10.1056/NEJMoa1800722 - DOI - PMC - PubMed
    1. Arnett DK, Blumenthal RS, Albert MA, et al. 2019. ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019:CIR0000000000000678. doi:10.1161/CIR.0000000000000678 - DOI - PubMed

Substances